An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2015
Price : $35 *
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Back pain; Osteoarthritis
- Focus Adverse reactions
- Sponsors Mallinckrodt Inc.
- 03 May 2014 Tolerability results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 13 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.